Skip to Main Content

Paper Details

Clinical implementation of integrated molecular-morphologic risk prediction for meningioma.
Brain Pathol
11
2023
CDKN2A/B, CNV, CNVs, IntS, TERT-promoter, brain tumor, chromosomal arm, epigenetic methylation, meningioma, meningioma tumors, patient, patients, tumor
Author NameAffiliation
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ)
Sebastian BrandnerNational Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust
Sebastian BrandnerQueen Square Institute of Neurology, University College London
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Andreas von DeimlingUniversity Hospital Heidelberg and CCU Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmUniversity Hospital Heidelberg and CCU Neuropathology, German Cancer Research Center (DKFZ)
Felix SahmUniversity Hospital Heidelberg and CCU Neuropathology, German Cancer Research Center (DKFZ)
Sybren L N MaasLeiden University Medical Center
Sybren L N MaasErasmus Medical Center
  • 1 - 12

Datasets

Release 1.2